Justin Ward
Director/Board Member bei RECCE PHARMACEUTICALS LTD
Vermögen: 86 533 $ am 31.03.2024
Profil
Justin Ward is currently the Executive Director & Manager-Quality Assurance at Recce Pharmaceuticals Ltd.
He previously worked as a Laboratory Manager at Solbec Pharmaceuticals Ltd.
and as a Quality Manager at Phebra Pty Ltd.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.12.2023 | 301 444 ( 0,15% ) | 86 533 $ | 31.03.2024 |
Aktive Positionen von Justin Ward
| Unternehmen | Position | Beginn |
|---|---|---|
| RECCE PHARMACEUTICALS LTD | Director/Board Member | 09.07.2019 |
Ehemalige bekannte Positionen von Justin Ward
| Unternehmen | Position | Ende |
|---|---|---|
Phebra Pty Ltd.
 Phebra Pty Ltd. Pharmaceuticals: MajorHealth Technology Phebra Pty Ltd. is an Australian-based specialty pharmaceutical group that develops, manufactures, and markets critical medicines worldwide. The private company is based in Lane Cove, AU, and has subsidiaries in the United Kingdom. The Australian company creates critical medicines that save and improve lives. Phebra was founded in 1993, and the CEO is Andre Vlok. | Corporate Officer/Principal | - |
| Solbec Pharmaceuticals Ltd. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RECCE PHARMACEUTICALS LTD | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Solbec Pharmaceuticals Ltd. | Health Technology |
Phebra Pty Ltd.
Phebra Pty Ltd. Pharmaceuticals: MajorHealth Technology Phebra Pty Ltd. is an Australian-based specialty pharmaceutical group that develops, manufactures, and markets critical medicines worldwide. The private company is based in Lane Cove, AU, and has subsidiaries in the United Kingdom. The Australian company creates critical medicines that save and improve lives. Phebra was founded in 1993, and the CEO is Andre Vlok. | Health Technology |
